Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

AOTI (LSE:AOTI) Shares Down 17% — Is Arizona Medicaid the Key Concern?

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research

Team Kalkine | 23 February 2026

Trellus Health (LSE:TRLS) Shares Jump 111% on Major Contract Extension

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.

Team Kalkine | 18 February 2026

Optima Health (LSE:OPT) Expands UK and Ireland Presence Through Strategic Acquisition

Optima Health (LSE:OPT), the UK’s prominent provider of technology-enabled corporate health and wellbeing solutions, has entered into a definitive agreement toacquirePAM Healthcare Limited, a leading occupational health and wellness provider in the UK and Republic of Ireland. The acquisition, valued at approximately GBP 100 …

Sonal Goyal | 16 February 2026

Inspiration Healthcare Group (AIM:IHC) Revenue Up 24%, FY27 Outlook Remains Positive

Inspiration Healthcare Group plc (AIM:IHC) shares gained 8.41% to GBX 18.70 during the morning session on 12 February 2026, following the release of its unaudited trading update for the year ended 31 January 2026.

Team Kalkine | 12 February 2026

PZ Cussons (LSE:PZC) H1 FY26 Operating Profit Climbs 32%, FY26 Guidance Raised

PZ Cussons plc (LSE:PZC) shares advanced 9.17% to GBX 87.66 during the morning session on 11 February 2026 after reporting its results for the six months ended 29 November 2025 (H1 FY26), alongside an upgrade to full-year operating profit expectations.

Team Kalkine | 11 February 2026

H1 FY26 Trading Update Triggers 24% Drop in Renalytix (LSE:RENX) Stock

Renalytix PLC (LSE:RENX) saw its share price fall sharply in early trading on 11 February, down 24.11% to4.25pat10:35 am, as investors reacted to the company’s trading update for the six months ended 31 December 2025 (H1 FY26). The decline comes amid indications of slower-than-anticipatedrevenuegrowth …

Sonal Goyal | 11 February 2026

Arecor (LSE:AREC) Up 37% in a Year: Why Investors Are Watching This Stock Today?

Arecor Therapeutics plc (LSE:AREC), the biopharmaceutical company focused on diabetes and cardiometabolic therapies, released an unaudited business update for the 12 months ending 31 December 2025. The report outlines developments across its core product areas, financial performance, and strategic collaborations, while the audited results …

Sonal Goyal | 09 February 2026

Verici Dx PLC (AIM:VRCI) Shares plunged 3% Despite FY25 Revenue Growth Update

Verici Dx PLC (AIM:VRCI) shares traded 3.10% lower to GBX 0.70 during the morning session on 5 February 2026, extending yearly decline to 81.27%, Today’s decline came despite the release of a trading update outlining revenue growth and commercial progress for the year ended …

Sonal Goyal | 05 February 2026

Jefferies Issues Buy on GSK (LSE:GSK) with 2,100p Target—What's the Play?

GSK plc (LSE:GSK) shares moved higher on Wednesday, trading at GBX 2,019.03, up 3.78% on the day. The stock has gained 46.31% over the past year and 10.91% over the last month.

Sonal Goyal | 04 February 2026

Analyst Split on hVIVO (LON:HVO): Hold or Buy After 69% Yearly Fall?

Shares in hVIVO PLC (LON:HVO) have fallen more than 69% over the past year, bringing renewed focus on analyst views and the company’s latest trading update. Despite the decline, broker opinions remain divided, with hold ratings from Stifel Europe and Panmure Liberum alongside a …

Team Kalkine | 02 February 2026

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions